Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 5, 2006, Pages 419-426

  Grandesso, Francesco ^a   Bachy, Catherine ^a   Donam, Issa ^b   Ntambi, John ^c   Habimana, Joseph ^c   D'Alessandro, Umberto ^d   Maikere, Jacob ^c   Vanlerberghe, Veerle ^c,d   Kerah, Clément Hinzoumbe ^b   Guthmann, Jean Paul ^a  

^a EPICENTRE   (France)

^b Programme National de Lutte Contre la Malaria   (Chad)

^c MÉDECINS SANS FRONTIÈRES   (Belgium)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Amodiaquine; Chad; Chloroquine; Malaria; Plasmodium falciparum; Resistance; Sulfadoxine pyrimethamine

Indexed keywords

AMODIAQUINE; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; FANSIDAR; PARACETAMOL;

ARTICLE; BLOOD SAMPLING; CHAD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POPULATION DISTRIBUTION; PRESCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; URBAN POPULATION; WORLD HEALTH ORGANIZATION;

AMODIAQUINE; ANIMALS; CHAD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GENES, PROTOZOAN; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; URBAN POPULATION;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 33644844646     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.07.017     Document Type: Article

References (27)

1. R.A. Bayoumi H.A. Babiker S.M. Ibrahim H.W. Ghalib B.O. Saeed S. Khider M. Elwasila E.A. Karim Chloroquine-resistant Plasmodium falciparum in eastern Sudan Acta. Trop. 46 1989 157-165
2. Bloland, P.B., 2001. Drug Resistance in Malaria. World Health Organization, Geneva, WHO/CDS/CSR/DRS/2001.4.
3. F. Checchi R. Durand S. Balkan B.T. Vonhm J.Z. Kollie P. Biberson E. Baron J. Le Bras J.P. Guthmann High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: Results in vivo and analysis of point mutations Trans. R. Soc. Trop. Med. Hyg. 96 2002 664-669
4. F. Checchi P. Piola C. Kosack E. Ardizzoni D. Klarkowski E. Kwezi G. Priotto S. Balkan N. Bakyaita A. Brockman J.P. Guthmann Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundibugyo, western Uganda Trop. Med. Int. Health 9 2004 445-450
5. EANMAT (The East African Network for Monitoring Antimalarial Treatment) The efficacy of antimalarial monotherapies, sulfadoxine-pyrimethamine and amodiaquine in East Africa: Implications for sub-regional policy Trop. Med. Int. Health 8 2003 860-867
6. O.J. Ekanem J.S. Weisfeld L.A. Salako B.L. Nahlen E.N. Ezedinachi O. Walker J.G. Breman O.J. Laoye K. Hedberg Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children Bull. World Health Organ. 68 1990 45-52
7. K. Marsh Malaria disaster in Africa Lancet 352 1998 924
8. T.K. Mutabingwa D. Anthony A. Heller R. Hallet J. Ahmed C. Drakeley B.M. Greenwood C.J.M. Whitty Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: A four-arm randomised effectiveness trial Lancet 365 2005 1474-1480
9. F. Nosten P. Brasseur Combination therapy for malaria. The way forward? Drugs 62 2002 1315-1329
10. P. Piola C. Fogg F. Bajunirwe S. Biraro F. Grandesso E. Ruzagira J. Babigumira I. Kigozi J. Kiguli J. Kyomuhendo L. Ferradini W. Taylor F. Checchi J.P. Guthmann Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: A randomised trial Lancet 365 2005 1467-1473
11. L.C. Ranford-Cartwright P. Balfe R. Carter D. Walliker Frequency of cross-fertilisation in the human malaria parasite Plasmodium falciparum Parasitology 107 1993 11-18
12. P. Ringwald A. Keundjian A. Same Ekobo L.K. Basco Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde Cameroon. Trop. Med. Int. Health 5 2000 620-627
13. A.M. Rønn H.A. Msangeni J. Mhina W.H. Wernsdorfer I.C. Bygbjerg High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania Trans. R. Soc. Trop. Med. Hyg. 90 1996 179-181
14. C.E. Rwagacondo C. Karema V. Mugisha A. Erhart J.C. Dujardin C. Van Overmeir P. Ringwald U. D'Alessandro Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria Trop. Med. Int. Health 9 2004 1091-1098
15. G. Snounou Genotyping of Plasmodium spp. Nested PCR Methods Mol. Biol. 72 2002 103-116
16. A. Sowunmi A.I. Ayede A.G. Falade V.N. Ndikum C.O. Sowunmi A.A. Adedeji C.O. Falade T.C. Happi A.M. Oduola Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children Ann. Trop. Med. Parasitol. 95 2001 549-558
17. K. Stepniewska W.R. Taylor M. Mayxay R. Price F. Smithuis J.-P. Guthmann K. Barnes H.Y. Myint M. Adjuik P. Olliaro S. Pukrittayakamee S. Looareesuwan T.T. Hien J. Farrar F. Nosten N.P. Day N.J. White In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up Antimicrobial Agents Chemother. 48 2004 4271-4280
18. E. Stivanello P. Cavailler F. Cassano S.A. Omar D. Kariuki J. Mwangi P. Piola J.P. Guthmann Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan Trop. Med. Int. Health 9 2004 975-980
19. A.O. Talisuna P. Langi N. Bakyaita T. Egwang T.K. Mutabingwa W. Watkins E. Van Mark U. D'Alessandro Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: What is the relationship between these three factors Trans. R. Soc. Trop. Med. Hyg. 96 2002 310-317
20. D.J. Terlouw B.L. Nahlen J.M. Courval S.K. Kariuki O.S. Rosenber A.J. Oloo M.S. Kolczak W.A. Hawley A.A. Lal F.O. Kuile Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing Antimicrobial Agents Chemother. 47 2003 2929-2932
21. J.F. Trape The public health impact of chloroquine resistance in Africa Am. J. Trop. Med. Hyg. 64S 2001 12-17
22. N.J. White P. Olliaro Strategy for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria Parasitol. Today 12 1996 399-401
23. N.J. White F. Nosten S. Looareesuwan W.M. Watkins K. Marsh R.W. Snow G. Kokwaro J. Ouma T.T. Hien M.E. Molyneux T.E. Taylor C.I. Newbold T.K. Ruebush M. Danis B.M. Greenwood R.M. Anderson P. Olliaro Averting a malaria disaster Lancet 353 1999 1965-1967
24. WHO, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Division of Control of Tropical Diseases, World Health Organization, Geneva, WHO/MAL/96.1077.
25. WHO, 2001. Antimalarial Drug Combination Therapy Report of a WHO Technical Consultation, Geneva, 4-5 April 2001. World Health Organization, Geneva, WHO/CDS/RBM/2001.35.
26. WHO, 2002. Monitoring Antimalarial Drug Resistance. Report of a WHO Consultation, Geneva 3-5 December 2001. World Health Organization, Geneva, WHO/CDS/CSR/EPH/2002.17.
27. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. World Health Organization, Geneva, WHO/HTM/RBM/2003.50.